|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 4.760 USD | 0.00% |
|
+3.48% | +235.21% |
| 08-19 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
| 08-13 | Edesa Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 16.33 | +243.14% | 3 | ||||||
| 186.27 | +18.92% | 18 | ||||||
| 1,162.61 | +9.64% | 15 | ||||||
| 200.18 | +58.02% | 22 | ||||||
| 103.61 | +16.97% | 20 | ||||||
| 49.16 | +13.1% | 24 | ||||||
| 2,427.12 | +10.47% | 15 | ||||||
| 1,397.26 | +3.5% | 8 | ||||||
| 618.43 | +24.48% | 18 | ||||||
| 53.69 | -9.2% | 16 | ||||||
| 678.06 | +24.96% | 16 | ||||||
| 110.18 | +27.39% | 11 | ||||||
| 21.01 | +66% | 13 | ||||||
| 134.69 | +73.07% | 21 | ||||||
| 109.9 | +48.61% | 20 | ||||||
| 109 | +78.19% | 9 | ||||||
| 100.21 | +43.81% | 16 | ||||||
| 12.75 | +55.68% | 4 | ||||||
| 119.71 | +37.21% | 14 | ||||||
| - | - | - | - | - | ||||
| Average | 400.54 | +44.42% | 15 | ||||||
| Weighted average by Cap. | 528.91 | +25.36% | 17 |
- Stock Market
- Stocks
- EDSA Stock
- Sector Edesa Biotech, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
